DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 171 filers reported holding DEPOMED INC in Q2 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $8,324,000 | +4.8% | 1,247,950 | +3.5% | 0.00% | 0.0% |
| Q1 2018 | $7,943,000 | -6.3% | 1,205,287 | +14.5% | 0.00% | 0.0% |
| Q4 2017 | $8,474,000 | +70.8% | 1,052,705 | +22.9% | 0.00% | 0.0% |
| Q3 2017 | $4,961,000 | -46.4% | 856,771 | -0.5% | 0.00% | -50.0% |
| Q2 2017 | $9,252,000 | -17.9% | 861,411 | -4.1% | 0.00% | 0.0% |
| Q1 2017 | $11,274,000 | -26.3% | 898,298 | +5.8% | 0.00% | -33.3% |
| Q4 2016 | $15,296,000 | -26.4% | 848,848 | +2.1% | 0.00% | -25.0% |
| Q3 2016 | $20,776,000 | +79.6% | 831,370 | +41.0% | 0.00% | +100.0% |
| Q2 2016 | $11,565,000 | +2621.2% | 589,470 | +1830.8% | 0.00% | – |
| Q1 2016 | $425,000 | -0.2% | 30,530 | +29.9% | 0.00% | – |
| Q4 2015 | $426,000 | -91.6% | 23,500 | -96.5% | 0.00% | -100.0% |
| Q3 2013 | $5,071,000 | -32.3% | 677,900 | -49.2% | 0.00% | 0.0% |
| Q2 2013 | $7,492,000 | – | 1,335,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 350,000 | $8,740,000 | 13.84% |
| Kavi Asset Management, LP | 568,800 | $14,647,000 | 12.61% |
| SCOGGIN MANAGEMENT LP | 2,806,000 | $70,066,000 | 12.05% |
| DELTEC ASSET MANAGEMENT LLC | 1,812,672 | $45,277,000 | 10.25% |
| Senvest Management, LLC | 4,129,099 | $103,103,000 | 7.39% |
| NAYA CAPITAL MANAGEMENT UK LTD | 1,983,068 | $49,557,000 | 5.52% |
| Starboard Value LP | 6,015,000 | $150,194,000 | 4.08% |
| SCOGGIN MANAGEMENT LP | 602,400 | $15,042,000 | 2.59% |
| OAK RIDGE INVESTMENTS LLC | 3,363,808 | $83,994,000 | 2.18% |
| PERKINS CAPITAL MANAGEMENT INC | 76,100 | $1,900,000 | 1.90% |